Methods Study to Characterize Early Indicators of Weight Loss in People
NCT ID: NCT00383253
Last Updated: 2009-03-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
57 participants
INTERVENTIONAL
2006-10-31
2008-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Investigating the Early Markers of Weight Loss
NCT04866875
The WEIGH Study: Weighing to Improve and Gain Health
NCT01369004
Weight Tracking and Weight Loss Outcomes: Establishing the Standard of Care
NCT01646086
Personalized Dietary Program and Markers of Wellness
NCT03424395
Adaptive Responses to Overfeeding and Weight
NCT03857048
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
10%
caloric restriction - 10%
Subjects maintained on 10% caloric restriction (caloric intake = 90% of baseline)
25%
caloric restriction - 25%
Subjects maintained on 25% caloric restriction (caloric intake = 75% of baseline)
50%
caloric restriction - 50%
Subjects maintained on 50% caloric restriction (caloric intake = 50% of baseline)
Control
caloric restriction - Control
Subjects maintained on their baseline caloric intake (caloric restriction = none)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
caloric restriction - 10%
Subjects maintained on 10% caloric restriction (caloric intake = 90% of baseline)
caloric restriction - 25%
Subjects maintained on 25% caloric restriction (caloric intake = 75% of baseline)
caloric restriction - 50%
Subjects maintained on 50% caloric restriction (caloric intake = 50% of baseline)
caloric restriction - Control
Subjects maintained on their baseline caloric intake (caloric restriction = none)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
55 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Adelaide
OTHER
Royal Adelaide Hospital
OTHER
Pfizer
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Pfizer, Inc.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Pfizer CT.gov Call Center
Role: STUDY_DIRECTOR
Pfizer
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Pfizer Investigational Site
Adelaide, South Australia, Australia
Pfizer Investigational Site
North Adelaide, South Australia, Australia
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
To obtain contact information for a study center near you, click here.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
A9001342
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.